Delivery Order SPE2DB20D3101-SPE2DB25FRKL6

Award Date 5/16/25
Potential Completion Date 5/19/25
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $2,304.57 and a completion date of March 21, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp is the prime contractor, and the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $1,638.00. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a medical product, with a ceiling value of $42,667.02 and a completion date of April 9, 2025. The contract is a firm fixed-price Delivery Order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a medication, with a ceiling value of $3,191.37. It is a firm fixed-price contract with an ultimate completion date of April 11, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a larger Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a medication, with a ceiling value of $3,685.50 and a period of performance through April 24, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $13,770.41 fixed-price contract is for the delivery of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a specialty medication, with a completion date of November 27, 2024. The contract is not designated as a set-aside, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $4,252.35 and a completion date of May 19, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,549.38 firm fixed-price contract is for the supply of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a performance period ending on April 11, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $4,865.73 and a period of performance through May 1, 2025. This contract is not designated as a set-aside and was awarded as a firm fixed-price delivery order. AmerisourceBergen Drug Corp holds a...
This is a $1,913.87 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a medication, with a completion date of May 13, 2025. The contract is a firm fixed-price delivery order, without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB25FRKL6
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a prescription medication, with a ceiling value of $3,057.09 and a completion date of May 19, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor for this award, and the place of performance is Conshohocken, Pennsylvania. The company also holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 8/17/25, 1:06 AM